Drug Shortage Report for BENZACLIN
| Report ID | 257530 |
| Drug Identification Number | 02248472 |
| Brand name | BENZACLIN |
| Common or Proper name | testst |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | CLINDAMYCIN BENZOYL PEROXIDE |
| Strength(s) | 1% 5% |
| Dosage form(s) | GEL |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 100s |
| ATC code | D10AF |
| ATC description | ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2025-01-01 |
| Actual start date | |
| Estimated end date | 2025-11-19 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-10-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-10-09 | English | Compare |
| v2 | 2025-10-09 | French | Compare |
| v1 | 2025-10-09 | English | Compare |
Showing 1 to 3 of 3